Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06999642 · ClinicalTrials.gov registry record · NA

Radicle GI Health™: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health

A NA study, sponsored by Radicle Science.

Completed
Registry status
NA
Development phase
450
Enrollment target

NCT06999642: Completed NA study, sponsored by Radicle Science.

NCT06999642 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 450 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06999642, a NA study, has completed, sponsored by Radicle Science.

COMPLETED
Registry status
NA
Development phase
450 participants
Enrollment target

Study Summary

A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on GI health and related health outcomes.

Primary Outcome

Difference between rates of change over time in DQLQ score as assessed by Digestion-associated QoL (scale 0-9; where the higher scores correspond to worse GI-related quality of life)

Interventions

  • DIETARY_SUPPLEMENT GI Health Placebo Control
  • DIETARY_SUPPLEMENT GI Health Active Product

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2025-05-29
Est. Completion 2025-09-08
Phase NA
Radicle Science

55 total trials

What the finished NCT06999642 record still lists

NCT06999642 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).

The record links to 0 conditions, and to 2 interventions - of which GI Health Placebo Control is the first listed.

NCT06999642 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06999642 about?

NCT06999642 is a clinical study titled "Radicle GI Health™: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health". A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on GI health and related health outcomes.

What is the current status of trial NCT06999642?

This trial is currently completed. It is a NA study. The enrollment target is 450 participants. The study started on 2025-05-29. Estimated completion is 2025-09-08.

What interventions are being tested in trial NCT06999642?

The interventions under investigation include: GI Health Placebo Control (DIETARY_SUPPLEMENT), GI Health Active Product (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06999642?

This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06999642's enrollment target sits among peer trials

450 225th of 2000 higher than 1,768 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00515060 · 450 participants

    Psychophysical Studies of Cancer Therapy Pain

  • NCT01257269 · 450 participants

    Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

  • NCT03047161 · 450 participants

    Electrophysiology of Fetal Arrhythmia

  • NCT03269630 · 450 participants

    New Orleans Pulmonary Hypertension Biobank

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06999642, the US trial registry maintained by the National Library of Medicine. NCT06999642 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.